$9.940
-0.319 (-3.21%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ZVRA Prediction & Forecast by Similar Chart Analysis
Alphio's ZVRA stock price prediction model matches the current Zevra Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.86 (-0.85%). The 1-week path is $9.59 (-3.50%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Zevra Therapeutics Inc Stock?
Zevra Therapeutics Inc (ZVRA) is a good buy right now due to its current price of $11.39, a strong RSI of 62.84 indicating bullish momentum, and a forward P/E of 10.67 suggesting it is undervalued compared to its growth potential. The recent Q2 earnings report showed a significant revenue increase of 53% year-over-year, reaching $39.7 million, which reflects strong market performance. However, the main risk is the negative opinion from the EMA regarding its drug application, which could impact future revenue streams.
ZVRA stock price ended at $9.94 on Friday, after losing -3.21%
Zevra Therapeutics Inc (ZVRA) last closed at $9.94, losing -3.21%. These facts feed the 1-day and 1-week ZVRA price prediction above.
Forecast Drivers
Zevra Therapeutics Inc (ZVRA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ZVRA, ranked by similarity.
Seasonality analysis for ZVRA
Historically the probability of a positive October return for ZVRA is 100.00%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ZVRA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $16.02 | $17.58 | $24.15 | +76.87% |
| Nov 2026 | $12.14 | $17.17 | $24.99 | +72.73% |
| Dec 2026 | $20.43 | $23.43 | $26.57 | +135.71% |
In 2026, Zevra Therapeutics Inc (ZVRA) is projected to range from $12.14 to $26.57.
Zevra Therapeutics Inc 2026 monthly forecast
In Oct 2026, Zevra Therapeutics Inc is projected to average $17.58, with a low of $16.02 and high of $24.15.
In Nov 2026, Zevra Therapeutics Inc is projected to average $17.17, with a low of $12.14 and high of $24.99.
In Dec 2026, Zevra Therapeutics Inc is projected to average $23.43, with a low of $20.43 and high of $26.57.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.